Non-thermal Infrared Light Treatment of Ischemia/Reperfusion Injury and Subsequent Analysis of Macrophage Differentiation

Summary

We describe the reduction of reperfusion injury by 670 nm irradiation in a mouse model of ischemia and reperfusion by tourniquet placement. This 670 nm irradiation reduced the inflammatory response, decreased the number of proinflammatory macrophages, and increased the protective macrophages.

Abstract

Tissue damage and necrosis from inflammatory processes are a consequence of ischemia reperfusion injury (IRI). In skeletal muscle, ischemia reduces the aerobic energy capacity of muscle cells, leading to adverse biochemical alterations and inflammation. The goal of this study is to show that exposure to near-infrared light (NIR) during a period of ischemia reduces IRI by decreasing necrosis and inflammation in addition to decreasing proinflammatory M1 and increasing protective M2 macrophages. C57/Bl6 mice underwent unilateral tourniquet-induced hindlimb ischemia for 3 h followed by reperfusion for either 15 or 30 min. Mice were randomly assigned to 3 groups. Group 1 underwent IRI with 30 min reperfusion. Group 2 underwent IRI with a 15 min reperfusion. Each group consisted of 50% no-NIR and 50% NIR-treated mice with exposure of 50 mW/cm² for 5 min/1 h after tourniquet closure. Group 3 were sham animals anesthetized for 3 h omitting IRI.

Laser doppler flow imaging was performed on all mice to confirm ischemia and reperfusion. Flow data were expressed as the ratio of ischemic limb and the contralateral control. The mice were euthanized after reperfusion, and the quadriceps and gastrocnemius were harvested. Immunoprecipitation and western blot of macrophage-markers CD68 (M1) and CD206 (M2) were performed and normalized to CD14 expression. The expression of the inflammatory markers CXCL1 and CXCL5 was significantly reduced by NIR in the IRI group. A significant decrease in CD68 and an increase in CD206 expression was observed in animals receiving IR and NIR. Tissue necrosis was decreased by NIR in the IRI group, as visualized by 2,3,5-triphenyltetrazolium chloride (TTC) staining. The findings demonstrate that exposure to NIR reduced IRI and improved tissue survival. NIR reduced inflammation, decreased proinflammatory M1, and increased protective M2 macrophages. Exposure to NIR reduced inflammation and enhanced regeneration, leading to tissue protection following ischemia.

Introduction

Ischemia reperfusion injury (IRI) is a clinical challenge seen following vascular injuries and the prolonged use of surgical tourniquets. Previous studies have shown that 60-90 min is the upper threshold for warm ischemia time, beyond which irreversible tissue damage can occur. More than any other single factor, the limitations of warm ischemia time limit the success and salvage of reimplantation of dysvascular limbs^1,2.

In skeletal muscle, ischemia reduces the aerobic capacity of cells, leading to acute inflammation and adverse biochemical alterations. These effects are worsened by reperfusion, which stimulates the recruitment of neutrophils and the production of free radicals, further damaging the skeletal muscle. This can occur from vascular occlusion, whether the result of injury or the intentional use of a tourniquet to prevent hemorrhage. Some of the key mediators in this process are myeloperoxidase (MPO), an enzyme expressed by neutrophils that is integral to the respiratory burst function and production of free radicals³, and chemokines such as CXCL1 and CXCL5 that serve to recruit neutrophils to sites of acute inflammation⁴.

The femoral artery was not dissected to mimic an open tourniquet in an emergency. This approach is also based on the reproducibility of creating ischemia and reperfusion as well as a consistent blood-free area. Previous research has demonstrated that exposure to non-thermal infrared (NIR) light with a wavelength of 670 nm can increase vascular collateralization in a mouse ischemic hindlimb with NIR exposure over days, mitigating the effects of IRI⁵. Additionally, prior research has demonstrated that NIR light can induce the polarization of macrophages into either proinflammatory (M1) or prohealing (M2) phenotypes⁶.

Any treatment that can minimize tissue damage and cellular death following hypoxia and reperfusion would be beneficial in increasing the success of limb salvage following vascular injuries. Therefore, the overall goal is to improve IRI by introducing 670 nm light treatment as a viable option to other treatment modalities. This paper is based on the hypothesis that exposure to NIR light during a period of ischemia decreases inflammation and tissue necrosis by decreasing the secretion of chemoattractant proteins and influx of inflammatory cells by inducing macrophages to take on an M2 phenotype.

Protocol

This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Institutional Animal Care and Use Committee (Protocol: AUA#1517). All research involving mice was conducted in conformity with PHS policy. 

1. Tourniquet placement

NOTE: A tourniquet was placed to induce ischemia and achieve a blood-free surgical field.

1. Anesthetize a C57/Bl6 mouse with isoflurane in the induction chamber at a concentration of 3-5%.
2. Remove the mouse from the induction chamber when it does not respond to toe pinches. Place the mouse in a nose cone for continued anesthesia at 1.5-2% on a heating pad with a non-reflective mat below a laser doppler imager (LDI).
3. Place the tourniquet around the left hindlimb (Figure 1).
   ​NOTE: Do not close the tourniquet yet. Measure the blood flow first (see section 2).

2. Blood flow measurement by LDI

NOTE: Blood flow was measured to confirm proper occlusion and reperfusion as described previously⁷.

1. Place the anesthetized mouse below the LDI (26 cm) onto a heating pad with a non-reflective surface in a prone position with stretched legs and paws facing upward.
2. Capture images by placing the mouse within the capturing area of the laser (16.1 cm x 16.1 cm).
   1. Adjust the laser to a scan speed of 4 ms/pixel. Capture images with the proprietary software by pushing the record button. Take images before, during occlusion, and during reperfusion by clicking on the record button.
      NOTE: The images are flow-related map images; red is good blood flow; blue is no blood flow. Confirm in the image that the occluded hindlimb is blue. Similarly, check the image to confirm that the previously occluded hindlimb is red on reperfusion. It is imperative to have a non-reflective mat for the LDI; otherwise, the reflection will affect the images.
3. Analyze the images with the provided software by defining a region of interest. Establish a ratio between the ischemic and control legs.

3. Ischemia and reperfusion protocol

1. Close the tourniquet around the anesthetized mouse's hindlimb for 3 h.
   NOTE: Tightening the tourniquet creates ischemia, interrupting the blood flow.
2. Open the tourniquet after 3 h of occlusion; open and perfuse the hindlimb for 15 or 30 min.

4. Tissue harvest

1. Increase anesthesia to 5% isoflurane to deeply anesthetize the mice. Perform a pneumothorax by opening the chest cavity with sharp scissors to ensure death. Harvest the gastrocnemii and the quadriceps muscles^8,9,10.
2. Snap-freeze the collected tissue in liquid nitrogen and store at -80 °C for further analysis.

5. NIR application

NOTE: NIR is applied to lower inflammation and reduce reperfusion injury.

1. Apply 670 nm NIR at an intensity of 100 mW for 5 min once per hour during occlusion.
2. Target the hindlimb with the fiber optic light source at a distance of 2.5 cm between the hindlimb and the light. Do not expose the contralateral leg to NIR (see Figure 1 for the setup).
3. Shine the NIR light for 5 min per hour for the duration of the ischemic period.
4. Instrument the sham group the same way. Do not close the tourniquet or apply NIR to the hindlimb.
   ​NOTE: The NIR light has a heat sink. The temperature does not increase within 5 min of light exposure¹¹.

6. Necrosis TTC

NOTE: Tissue necrosis is assessed to visualize the reduction of necrosis in muscle tissue.

1. Stain fresh quadriceps muscles with TTC at 37 °C for 20-30 min in 1% TTC in 0.1 M phosphate buffer adjusted to pH 7.4.
2. Observe red, stained live tissue based on the presence of a formazan precipitate.
   NOTE: The red staining is based on the reduction of TTC by dehydrogenase enzymes in healthy tissue. Necrotic tissue is unstained¹⁰.
3. Capture images of TTC-stained slices for analysis and measure the necrotic region by defining a region of interest.

7. Western analysis for chlorotyrosine

1. Subject mice to the ischemia/reperfusion protocol (section 3).
2. Harvest tissues (section 4) and isolate protein as previously described¹². Determine the protein concentration by the Bradford assay¹³.
3. Use the total protein lysate to perform electrophoresis and blot for 3-chlorotyrosine as described previously¹².
4. Perform a western blot on lysates of the gastrocnemii.
   1. Add Laemmli sample buffer containing 5% mercaptoethanol to the samples to obtain a concentration of 25 µg of total protein in 40 µL.
   2. Run the samples on a 4-15% Tris-glycine extended gel (see the Table of Materials) at 50 mV for 5 min. Increase the voltage to 100 mV for 1 h until the dye front runs out.
5. Incubate the gel in 1x transfer buffer (25 mM Tris, 190 mM glycine, 20% methanol; adjust the pH to 8.3 if necessary) for 10 min.
6. Assemble the transfer sandwich (sponge, filter, gel, cellulose membrane, filter, sponge). Place a reusable ice pack in the transfer apparatus. Transfer for 30 min in the cold room at 100 mA.
   ​NOTE: Ensure that no bubbles are trapped in the transfer sandwich, the blot is on the cathode and the gel on the anode.
7. Rinse the blot and block it in blocking buffer (see the Table of Materials) with 0.05% Tween for 30 min at room temperature. Wash the blot with Tris-buffered saline (TBS) containing 5% Tween three times for 5 min each before adding the primary antibody.
8. Incubate overnight with the primary polyclonal antibodies to 3-chlorotyrosine. Dilute the antibodies in blocking buffer with 0.05% Tween (1:1,000).
9. Use horseradish peroxidase (HRP)-conjugated donkey anti-mouse IgG and HRP-anti-goat IgG (1:10,000 dilution) as secondary antibodies.
10. Visualize bands of identity in the blots using enhanced chemiluminescence (ECL) reagent and an imaging system.
    1. Mix components based on the manufacturer's protocol and incubate them with the blot for 3 min to bind the ECL reagents to the bands of interest.
    2. Image the blot with an imaging system (see the Table of Materials). Use imaging software such as ImageJ to measure the density and normalize the density values of the bands of interest to those of the control bands.

8. ELISA for CXCL1 and CXCL5

1. Isolate total protein from the gastrocnemii muscles as described previously¹².
2. Assess the degree of inflammation by ELISA for CXCL1 and CXCL5 as previously described¹⁴ and according to the manufacturer's instructions.

9. Immunoprecipitation followed by western analysis

1. Subject the mice to the ischemia/reperfusion protocol (section 3).
2. Harvest the tissues (section 4) and isolate protein as previously described¹². Determine the protein concentration by the Bradford Assay¹³.
3. To concentrate the macrophage fraction of the total protein lysate, perform an immunoprecipitation for CD14 as described previously¹⁵.
4. Use the CD14 immunoprecipitate to perform electrophoresis and blot for CD206 and CD68 as described previously¹².
5. Perform a western blot on lysates of the gastrocnemii as described in section 7.
6. Incubate the immunoprecipitates overnight with the primary polyclonal antibodies to CD206 or CD68. Dilute the antibodies 1:200 in TBS.
7. Use HRP-conjugated donkey anti-mouse IgG and HRP-anti-goat IgG (1:10,000 dilution) as secondary antibodies.
8. Apply ECL reagent to the blot after mixing components based on the manufacturer's protocol and incubate for 3 min to visualize the bands of interest. Image the blot using an imaging system.

10. Statistical analysis

1. Perform statistical analysis of data within and between groups with analysis of variance (ANOVA) for repeated measures followed by Bonferroni's modification of Student's t-test, p ≤ 0.05.
2. Express data as mean ± standard error of the mean (SEM) or mean ± standard deviation (SD).

Results

Flow measurements confirmed ischemia and reperfusion
NIR light placement and the experimental protocol are depicted in Figure 1. A murine hindlimb ischemia model was developed and employed to assess the effect of NIR exposure on skeletal muscle IRI. As was expected, laser doppler flux imaging (Figure 2A) verified that the tourniquet was effective at inducing ischemia along with a return in blood flow to near-baseline for both NIR-treated (n ...

Discussion

This paper describes one of the first studies to focus on the reduction of reperfusion injury by NIR light treatment by changing the inflammatory response in the hindlimb. Ischemia reperfusion injury and NIR light treatment are not entirely novel. Other studies focused on ischemia reperfusion by NIR light. NIR light treatment has been successfully used in the reduction of myocardial infract size and reduction of renal damage after ischemia reperfusion injury. Quirk et al. reported a reduction in myocardial infarct size a...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
2,3,5-Triphenyltetrazolium	Sigma Aldrich	17779-10X10ML-F	1% solution
4–15% Criterio TGX Stain-Free Protein Gel	BioRad	#5678084	Tris-glycine extended gels
4x Laemmli Sample Buffer - 1610747	BioRad	16110747
670 nm light source	NIR Technologies		custom made
BCA Protein Assay Kit	Thermo Fisher	23227
BioRad ChemiDoc	Bio-Rad		Imaging system
Bio-Rad
β-mercaptoethanol	BioRad	1610710
CXCL1 ELISA	R&D Systems	DY453-05
CXCL5 ELISA	R&D Systems	DX000
Forane	Baxter	1001936040	isoflurane inhalant
goat anti-rabbit IgG-HRP	Santa Cruz Biotechnologies	sc-2004	1:10,000 dilution
Ice Accu ice pack
Laser doppler Imager	Moor	MOORLDI2-HIR
monoclonal CD14 antibody	Santa Cruz Biotechnologies	sc-515785	1:200 dilution
monoclonal CD206 antibody	Santa Cruz Biotechnologies	sc-58986	1:200 dilution
monoclonal CD68 antibody	Santa Cruz Biotechnologies	sc-20060	1:200 dilution
Pierce Protein free (TBS) blocking buffer			blocking buffer
polyclonal Chlorotyrosine Antibody	Hycult	HP5002	1:1,000 dilution
Protein A/G PLUS-Agarose	Santa Cruz Biotechnologies	sc-2003
Super Signal West Femto	ThermoFisher	34095	enhanced chemiluminescence reagent